The purpose of this study was to estimate the prevalence of psychiatric and personality disorders among industrial workers with substance use disorders and to investigate the association between this comorbidity and drug-related problems. A total of 353 industrial workers were included in the study. Sociodemographic and clinical data were collected from participants. Compared to controls, workers with substance use disorders were about 19 and 8 times more likely to have psychiatric and personality disorders, respectively. Anxiety (35.4%) and mood disorders (29.2%) were the most common psychiatric disorders among substance use workers. The most common personality disorders among substance use workers included antisocial and borderline (24.6% and 16.9%, respectively). There was a significant association between drug-related problems/dependence and psychiatric (χ2 = 14.04; p < 0.001) and personality disorders (χ2 = 18.74; p < 0.001). Psychiatric and personality disorders are common among substance use workers and are associated with drug-related problems.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Ahmad, B., Mufti, K. A., & Farooq, S. (2001). Psychiatric comorbidity in substance abuse (Opioids). JPMA, 51, 183–190.
Bassiony, M. M., Salah El-Deen, G. M., Yousef, U., Raya, Y., Abdel-Ghani, M. M., El-Gohari, H., & Atwa, S. A. (2015). Adolescent tramadol use and abuse in Egypt. The American Journal of Drug and Alcohol Abuse, 41(3), 206–211. https://doi.org/10.3109/00952990.2015.1014959.
Bassiony, M. M., Youssef, U. M., Hussein, R. A., & Saeed, M. (2016). Psychiatric comorbidity among Egyptian patients with opioid use disorders attributed to tramadol. Journal of Addiction Medicine, 10, 262–268.
Bassiony, M. M., Abdelghani, M., Salah El-Deen, G. M., Hassan, M. S., El-Gohari, H., & Youssef, U. M. (2018). Opioid use disorders attributed to tramadol among Egyptian university students. Journal of Addiction Medicine, 12(2), 150–155. https://doi.org/10.1097/ADM.0000000000000380.
Bassiony, M. M., Fawzy, M., Negm, M., Ibrahim, E., Ibrahim, D., Mokhtar, D., Abdallah, A., & Saad, A. (2019). Substance use disorders among industry workers in Egypt. Addictive Disorders and Their Treatment. https://doi.org/10.1097/ADT.0000000000000162.
Berman, A. H., Bergman, H., Palmstierna, T., & Schlyter, F. (2005). Evaluation of the drug use disorders identification test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample. European Addiction Research, 11, 22–31.
Bush, D. M., & Lipari, R. N. (2015). The CBHSQ Report. Rockville (MD): Substance Abuse and Mental Health Services Administration (US).
Dean, A. G., Arner, T. G., Sunki, G. G., Friedman, R., Lantinga, M., Sangam, S., Zubieta, J. C., Sullivan, K. M., Brendel, K. A., Gao, Z., Fontaine, N., Shu, M., Fuller, G., Smith, D. C., Nitschke, D. A., & Fagan, R. F. (2011). Epi Info™, a database and statistics program for public health professionals. Atlanta: CDC.
Demetrovics, Z. (2009). Co-morbidity of drug addiction: an analysis of epidemiological data and possible etiological models. Addiction Research and Theory, 17(4), 420–431. https://doi.org/10.1080/16066350802601324.
Fawzi, M. M. (2010). Some medicolegal aspects concerning tramadol abuse: the new Middle East youth plague: an Egyptian overview. Egyptian Journal of Forensic Sciences, 1, 99–102.
First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. W. (1996). Structured clinical interview for DSM-IV axis I disorders, clinician version (SCIDCV). Washington, DC: American Psychiatric Press.
First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. (1997). Structured clinical interview for DSM-IV—clinical version (SCID-CV) (User's Guide and Interview). Washington, D.C.: American Psychiatric Press, Inc.
Glassman, A. H. (1993). Cigarette smoking: implications for psychiatric illness. The American Journal of Psychiatry, 150(4), 546–553.
Goplerud, E., Hodge, S., & Benham, T. (2017). A substance use cost calculator for US employers with an emphasis on prescription pain medication misuse. Journal of Occupational and Environmental Medicine, 59(11), 1063–1071. Published online 2017 Sep 20.. https://doi.org/10.1097/JOM.0000000000001157.
Grant, B. F., Goldstein, R. B., Saha, T. D., Chou, S. P., Jung, J., Zhang, H., Pickering, R. P., Ruan, W. J., Smith, S. M., Huang, B., & Hasin, D. S. (2015). Epidemiology of DSM-5 alcohol use disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions III. JAMA Psychiatry, 72(8), 757–766. https://doi.org/10.1001/jamapsychiatry.2015.0584.
Kessler, R. C. (2012). The costs of depression. Psychiatric Clinics of North America, 35(1), 1–14. https://doi.org/10.1111/j.17470285.2012.01428.x.
Kessler, R. C., Nelson, C. R., McGonagle, K. A., Edlund, M. J., Frank, R. G., & Leaf, P. J. (1996). The epidemiology of co-occurring addictive and mental disorders: implications for prevention and services utilization. The American Journal of Orthopedics, 66, 17–31.
Khantzian, E. J. (1985). The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. American Journal of Psychiatry, 142(11), 1259–1264.
Khantzian, E. J. (1997). The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harvard Review of Psychiatry, 4(5), 231–244.
Kraemer, H. C., Stice, E., Kazdin, A., Offord, D., & Kupfer, D. (2001). How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors. American Journal of Psychiatry, 158(6), 848–856. https://doi.org/10.1176/appi.ajp.158.6.848.
Kutlu, M. G., & Gould, T. J. (2015). Nicotine modulation of fear memories and anxiety: implications for learning and anxiety disorders. Biochemical Pharmacology, 97, 498–511.
Lai, H. M. X., Cleary, M., Sitharthan, T., & Hunt, G. E. (2015). Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990–2014: a systematic review and meta-analysis. Drug and Alcohol Dependence, 154, 1–13. https://doi.org/10.1016/j.drugalcdep.2015.05.031.
Lasser, K., Boyd, J. W., Woolhandler, S., Himmelstein, D. U., McCormick, D., & Bor, D. H. (2000). Smoking and mental illness: a population-based prevalence study. JAMA, 284(20), 2606–2610.
McLellan, A. T., Luborsky, L., Woody, G. E., & O’Brien, C. P. (1980). An improved diagnostic evaluation instrument for substance abuse patients: The Addiction Severity Index. The Journal of Nervous and Mental Disease, 168, 26–33.
Merikangas, K. R., & Mcclair, V. L. (2012). Epidemiology of substance use disorders. Human Genetics, 131(6), 779–789. https://doi.org/10.1007/s00439-012-1168-0.
Mohamed, R. N., Hammad, S. A., EL Hamrawy, L. G., Rajab, A. Z., El Bahy, M. S., Soltan, M. R. (2013). Dual diagnosis and psychosocial correlates in substance abuse in Menoufia, Egypt, Menoufia Medical Journal, 26, 114–121.
Mojtabai, R., Olfson, M., & Mechanic, D. (2002). Perceived need and help-seeking in adults with mood, anxiety, or substance use disorders. Archives of General Psychiatry, 59, 77–84. https://doi.org/10.1001/archpsyc.59.1.77.
Prior, K., Mills, K., Ross, J., & Teesson, M. (2017). Substance use disorders comorbid with mood and anxiety disorders in the Australian general population. Drug and Alcohol Review, 36(3), 317–324. https://doi.org/10.1111/dar.12419.
Roche, A. M., Fischer, J., Pidd, K., Lee, N., Battams, S., & Nicholas, R. (2012). Workplace mental illness and substance use disorders in male-dominated industries: a systematic literature review. In National Centre for Education and Training on Addiction (NCETA) report. Australia: Flinders University.
Sareen, J., Chartier, M., Kjernisted, K. D., & Stein, M. B. (2001). Comorbidity of phobic disorders with alcoholism in a Canadian community sample. Canadian Journal of Psychiatry, 46, 733–740.
Sareen, J., Chartier, M., Paulus, M. P., & Stein, M. B. (2006). Illicit drug use and anxiety disorders: findings from two community surveys. Psychiatry Research, 142(1), 11–17. https://doi.org/10.1016/j.psychres.2006.01.009.
Slyepchenko, A., Brunoni, A. R., McIntyre, R. S., Quevedo, J., & Carvalho, A. F. (2016). The adverse effects of smoking on health outcomes in bipolar disorder: a review and synthesis of biological mechanisms. Current Molecular Medicine, 16, 187–205.
Spitzer, R. L., Williams, J. B. W., Gibbon, M., & First, M. B. (2009). Structured clinical interviews for DSM-IIIR-Patient Addiction (SCID-P) 1990. Washington, DC: American Psychiatric Press. SPSS Inc Released 2009. PASW Statistics for Windows, Version 18.0. Chicago: SPSS Inc.
SPSS Inc Released 2009. PASW Statistics for Windows, Version 18.0. Chicago: SPSS Inc.
Trull, T. J., Jahng, S., Tomko, R. L., Wood, P. K., & Sher, K. J. (2010). Revised NESARC personality disorder diagnoses: gender, prevalence, and comorbidity with substance dependence disorders. Journal of Personality Disorders, 24(4), 412–426. https://doi.org/10.1521/pedi.2010.24.4.412
U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration Drugs in the workplace: what an employer needs to know, Available at: http://workplace.samhsa.gov/DrugTesting/Files_Drug_Testing/FactSheet/factsheet041906.aspx. Accessed November 10th, 2018.
U.S. Food & Drug Administration (FDA) (2018) Drugs of abuse home use test. https://www.fda.gov/medical-devices/drugs-abuse-tests/drugs-abuse-home-use-test accessed 16th October 2019.
Walley, A. Y., Paasche-Orlow, M., Lee, E. C., Forsythe, S., Chetty, V. K., Mitchell, S., & Jack, B. W. (2012). Acute care hospital utilization among medical inpatients discharged with a substance use disorder diagnosis. Journal of Addiction Medicine, 6(1), 50–56.
Zhou, H., Polimanti, R., Yang, B. Z., Wang, Q., Han, S., Sherva, R., Nuñez, Y. Z., Zhao, H., Farrer, L. A., Kranzler, H. R., & Gelernter, J. (2017). Genetic risk variants associated with comorbid alcohol dependence and major depression. JAMA Psychiatry, 74(12), 1234–1241. https://doi.org/10.1001/jamapsychiatry.2017.3275.
Ziedonis, D., Hitsman, B., Beckham, J. C., Zvolensky, M., Adler, L. E., Audrain-McGovern, J., Breslau, N., Brown, R. A., George, T. P., Williams, J., Calhoun, P. S., & Riley, W. T. (2008). Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine & Tobacco Research, 10(12), 1691–1715. https://doi.org/10.1080/14622200802443569.
Conflict of Interest
The authors declare that they have no conflict of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Bassiony, M.M., Ibrahim, E.F. & Youssef, U.M. Association Between Dual Diagnosis and Drug-Related Problems in Workplace in Egypt: A Case-Control Study. Int J Ment Health Addiction 19, 240–251 (2021). https://doi.org/10.1007/s11469-019-00170-6
- Substance abuse
- Industrial workers